Tellus BioVentures

Tellus BioVentures is a biotechnology investment fund focused on early-stage innovation and company formation.

About Us

Tellus BioVentures is a biotechnology investment fund focused on early-stage innovation and company formation.

About Us

Featured News

Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform

05/18/21 Interius BioTherapeutics, a preclinical stage gene therapy company developing a paradigm-shifting platform for in vivo cell-specific gene delivery, today announced that it has raised $76 million in an oversubscribed Series A financing.

Two M&A deals and $9B later, Lonnie Moulder is ramping up his latest biotech startup. And this one comes with global vision built in.

03/23/21 Lonnie Moulder may have been in silent running mode in the 2 years since he closed the $5 billion sale of TESARO to GlaxoSmithKline. But he hasn’t been idle.

Mission

To uncover and accelerate promising life science innovation
To enable talented entrepreneurs and innovators
To serve patients with unmet needs

Learn More

Investments

We make select early investments at the Seed stage in private biotech ventures as the lead or sole investor and participate in Series-A investments.

Company Formation

We launch and fund de novo companies to advance important innovations that may otherwise lack the proper resources to progress efficiently.

Approach & portfolio